Evaluation of liposomal and conventional formulations of octyl methoxycinnamate on human percutaneous absorption using the stripping method

Journal of Cosmetic Science

Volumn 59, Issue 5, 2008, Pages 385-398

  Golmohammadzadeh, S ^a,b   Jaafari, M R ^a   Khalili, N ^a,b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CINNAMIC ACID DERIVATIVE; LIPOSOME; OCTYLMETHOXYCINNAMATE; SUNSCREEN;

ADULT; ARTICLE; EMULSION; FEMALE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MALE; SKIN ABSORPTION;

ADMINISTRATION, CUTANEOUS; ADULT; CINNAMATES; EMULSIONS; FEMALE; HUMANS; LIPOSOMES; MALE; SKIN ABSORPTION; SUNSCREENING AGENTS;

EID: 56049121721     PISSN: 15257886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. M. R. M. Santoro, G. D. A. Oliveira, E. R. M. Kedor-Hackmann, and A. K. Singh, The effect of packaging materials on the stability of sunscreen emulsions, Int. J. Pharm., 297, 197-203 (2005).
2. J. B. Wilkinson and R. J. Moore, in Harry's Cosmeticology (Longman Scientific & Technical, Singapore, 1996), pp. 222-260.
3. G. J. Clydesdale, G. W. Dandie, and H. K. Muller, Ultraviolet light induced injury: Immunological and inflammatory effects, Immunol. Cell biol., 79, 547-568 (2001).
4. W. Ting, C. D. Vest, and R. Sontheimer, Practical and experimental consideration of sun protection in dermatology, Int. J. Dermatol., 42, 505-513 (2003).
5. D. A. Godvin, N. H. Kim, and L. A. Felton, Influence of transcutol CG on the skin accumulation and transdermal permeation of ultraviolet absorbers, Eur. J. Pharm. Biopharm., 53, 23-27 (2002).
6. C. Couteau, N. P. Cullel, A. E. Connan, and L. J. M., Coiffard, Stripping method to quantify absorption of two sunscreens in humans, Int. J. Pharm., 222, 153-157 (2001).
7. P. Treffel and B. Gabard, Skin penetration and sun protection factor of ultra-violet filters from two vehicles, Pharm. Res., 13, 770-774 (1996).
8. D. D. Verma, S. Verma, G. Blume, and A. Fahr, Particle size of liposomes influences dermal delivery of substances into skin, Int. J. Pharm., 258, 141-151 (2003).
9. M. Foldvari, Effect of vehicle on topical liposomal drug delivery, petrolatum bases, J. Microencapsul., 13, 589-600 (1996).
10. M. Mezei, "Liposomes and the Skin," in Liposomes in Drug Delivery, G. Gregoriadis, A. T. Florence, and H. M. Patel., Eds. (Harwood Academic Publishers GmbH, Switzerland, 1993), Vol. 2, pp. 125-135.
11. G. Potard, C. Laugel, A. Baillet, H. Schaefer, and J. P. Marty, Quantitative HPLC analysis of sunscreens and caffeine during in vitro percutaneous penetration studies, Int. J. Pharm., 189, 249-260 (1999).
12. E. Chatelain, B. Gabard, and C. Surber, Skin penetration and sun protection factor of five UV filters: Effect of the vehicle, Skin Pharmacol. Appl. Skin Physiol., 16, 28-35 (2003).
13. C. Fernandez, G. Marti-Mestres, J. Ramos, and H. Maillols, LC analysis of benzophenone-3: II application to determination of "in vitro" and "in vivo" skin penetration from solvents, coarse and submicron emulsions, J. Pharm. Biomed. Anal., 24, 155-165 (2000).
14. H. Gustavsson, A. Farbrot, and O. Larko, Percutaneous absorption of benzophenone-3, a common component of topical sunscreens, Clin. Exp. Dermatol., 27, 691-694 (2002).
15. M. M. Jimenez, J. Pelletier, M. F. Bobin, and M. C. Martini, Influence of encapsulation on the in vitro percutaneous absorption of octyl methoxycinnamate, Int. J. Pharm., 272, 45-55 (2004).
16. L. Brinon, S. Geiger, V. Alard, J. Doucet, J. Tranchant, and G. Couarraze, Percutaneous absorption of sunscreens from liquid crystalline phases, J. Control. Release, 60, 67-76 (1999).
17. S. A. Wissing and R. H. Muller, Solid lipid nanoparticles as carrier for sunscreens: In vitro release and in vivo skin penetration, J. Control. Release, 81, 225-233 (2002).
18. M. Mezei and V. Gulasekharam, Liposomes - a selective drug delivery system for the topical route of administration: A gel dosage form, J. Pharm. Pharmacol., 34, 473-474 (1982).
19. M. Foldvari, A. Gesztes, and M. Mezei, Dermal drug delivery by liposome encapsulation: Clinical and electron microscopic studies, J. Microencapsul., 7, 479-482 (1990).
20. M. Mezei, Multiphase liposomal drug delivery system, US Patent. No. 4,761,288 (1988).
21. G. Gregoriadis, C. Kirby, P. Large, A. Meehan, and J. Senior, "Targeting of Liposomes: Study of Influence Factors," in Targeting of Drugs, G. Gregoriadis and J. Senior, Eds. (Plenium Press, New York, 1981), pp. 155-184.
22. L. Coderch, M. Oliva, A. Pons, A. de la Maza, A. M. Manich, and J. L. Parra, Percutaneous penetration of liposomes using the tape stripping technique, Int. J. Pharm., 139, 197-203 (1996).
23. M. Foldvari, J. Blair, and J. N. Oguejiofor, Topical dosage form of liposomal tetracaine: Effect of additives on the in vitro release and in vivo efficacy, J. Control. Release, 27, 193-205 (1993).
24. V. Gabrijelcic, M. Sentjurc, and M. Schara, The measurement of liposome entrapped molecules penetration into the skin: A 1D-EPR and EPR kinetic imaging study, Int. J. Pharm., 102, 151-158 (1994).
25. M. Kirjavainen, A. Urtti, R. Valjakka-Koskela, J. Kiesvaara, and J. Monkkonen, Liposome-skin interactions and their effects on the skin permeation of drugs, Eur, J. Pharm. Biopharm., 7, 279-286 (1999).
26. C. Michel, T. Purmann, E. Mentrup, E. Seiller, and J. Kreuter, Effect of liposomes on percutaneous penetration of lipophilic materials, Int. J. Pharm., 84, 93-105 (1992).
27. Food and Drug Administration, U.S. Department of Health and Human Services, Sunscreen drug products for over the counter human use: Final monograph, Federal Register, May 21, 1999, 64, 98, pp. 27666-27693.
28. M. Foldvari, Biphasic liposomes, US Patent No. 5,85.3,755 (1998).
29. R. R. C. New, C. D. V. Black, R. J. Parker, A. Puri, and G. L. Scherphof, "Liposomes in Biological Systems," in Liposomes: A Practical Approach, R. R. C. New, Ed. (Oxford University Press, New York, 1990), pp. 91-95, 105-160, 221-252.
30. A. Chisvert, M. C. Pascual-Marti, and A. Salvador, Determination of UV-filters in sunscreens by HPLC, Fresenius, J. Anal. Chem., 369, 638-641 (2001).
31. J. Y. Fang, T. L. Hwang, Y. L. Huang, and C. L. Fang, Enhancement of the transdermal delivery of catechins by liposomes incorporating anionic surfactants and ethanol, Int. J. Pharm., 310, 131-138 (2006).
32. J. M. López-Pinto, M. L. González-Rodríguez, and A. M. Rabasco, Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes, Int. J. Pharm., 298, 1-12 (2005).
33. E. Touitou, N. Dayan, L. Bergelson, B. Godin, and M. Eliaz, Ethosomes-novel vesicular carriers for enhanced delivery: Characterization and skin penetration properties, J. Control. Release, 65, 403-418 (2000).
34. Australian/New Zealand Standard, Sunscreen products: Evaluation and classification (1998), AS/NZS 2604:1998, pp. 1-32.
35. P. J. Matts, Solar ultraviolet radiation: Definitions and terminology, Dermatologie Clinics, 24, 1-8 (2006).
36. V. Sarveiya, S. Risk, and H. A. E. Benson, Liquid Chromatographic assay for common sunscreen agents: Application to in vivo assessment of skin penetration and systemic absorption in human volunteers, J. Chromatogr. B., 803, 225-231 (2004).
37. I. Alberti, Y. N. Kalia, A. Naik, J. Bonny, and R. H. Guy, In vivo assessment of enhanced topical delivery of terbinafine to human stratum corneum, J. Control, Release, 71, 319-327 (2001).
38. C. Padula, G. Colombo, S. Nicoli, P. L. Catellani, G. Massimo, and P. Santi, Bioadhesive film for the transdermal delivery of lidocaine: In vitro and in vivo behavior, J. Control. Release, 88, 277-285 (2003).
39. M. Sentjurc, K. Vrhovnik, and J. Kristl, Liposomes as a topical delivery system: The rule of size on transport studied by the EPR imaging method, J. Control. Release, 59, 87-97 (1999).
40. M. Ghyczy and J. Gareiss, Liposomes from vegetable phosphatidylcholine, Cosmet. Toiletr. 109, 75-81 (1994).
41. E. Ramon, C. Alonso, L. Coderch, A. de la Maza, O. Lopez, J. L. Parra, and J. Notario, Liposomes as alternative vehicles for sun filter formulations, Drug Delivery, 12, 83-88 (2005).
42. R. C. Wester and H. I. Maibach, "In Vivo Methods for Percutaneous Absorption Measurements," in Percutaneous Absorption Drugs Cosmetic Mechanisms Methodology, R. L. Bronaugh, Ed. (Marcel Dekker, New York, 1999), pp. 215-225.
43. A. Rougier, D. Dupuis, C. Lotte, R. Rouguet, and H. Schaefer, In vivo correlation between stratum corneum reservoir function and percutaneous absorption, J. Invest. Dermatol., 81, 275-278 (1983).
44. N. Skalko, M. Cajkovab, and I. Jalsenjak, Liposomes with clindamycin hydrochloride in the therapy of Acne vulgaris, Int. J. Pharm., 85, 97-101 (1991).
45. J. Du Plessis, C. Ramachandran, N. Weiner, and D. G. Muller, The influence of particle size of liposomes on the disposition of drugs into the skin, Int. J. Pharm., 103, 277-282 (1994).